Literature DB >> 12718577

Cervical Cancer: Etiology, Pathogenesis, Treatment, and Future Vaccines.

Shin-Je Ghim1, Partha Sarathi Basu, AB Jenson.   

Abstract

Cervical cancer is a sexually transmitted disease caused by the human papillomavirus (HPV), especially HPV-16 and -18. Of the half million new cases of cervical cancer reported yearly, 20% occur in India. Mass cancer screening programs to detect and treat cervical cancer and its precursor lesions are not available in India and most other developing countries because of the lack of resources. Curative and palliative treatments are not the same for all patients with cervical cancer because the result depends on the immunological response of the patient. This article describes the natural history of cervical carcinogenesis and the rational behind various modalities of prevention and treatment for the practising gynecological oncologist. Prophylactic vaccines against HPV-16 and -18 and therapeutic vaccines against cervical cancers should be able to overcome the logistical problems that now exist to screen, diagnose and treat cervical cancer and its precursor lesions.

Entities:  

Year:  2002        PMID: 12718577

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Safety and immunogenicity profile of human papillomavirus-16/18 AS04 adjuvant cervical cancer vaccine: a randomized controlled trial in healthy adolescent girls of Bangladesh.

Authors:  Sabera Khatun; Syed Md Akram Hussain; Sameena Chowdhury; Jannatul Ferdous; Fawzia Hossain; Sultana Razia Begum; Munira Jahan; Shahina Tabassum; Shahla Khatun; A B M Fazlul Karim
Journal:  Jpn J Clin Oncol       Date:  2012-01       Impact factor: 3.019

2.  Pap smear screening in the primary health care setting: A study from Turkey.

Authors:  Hande Celik Mehmetoglu; Ganime Sadikoglu; Alis Ozcakir; Nazan Bilgel
Journal:  N Am J Med Sci       Date:  2010-10

3.  Rel/Nuclear factor-kappa B apoptosis pathways in human cervical cancer cells.

Authors:  Marlene F Shehata
Journal:  Cancer Cell Int       Date:  2005-04-27       Impact factor: 5.722

4.  Survival status and associated factors of death among cervical cancer patients attending at Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia: a retrospective cohort study.

Authors:  Mulugeta Wassie; Zeleke Argaw; Yosief Tsige; Mesfin Abebe; Sezer Kisa
Journal:  BMC Cancer       Date:  2019-12-16       Impact factor: 4.430

5.  Detection of Immunoglobulin G against E7 of Human Papillomavirus in Non-Small-Cell Lung Cancer.

Authors:  Raul Storey; Joongho Joh; Amy Kwon; A Bennett Jenson; Shin-Je Ghim; Goetz H Kloecker
Journal:  J Oncol       Date:  2013-03-03       Impact factor: 4.375

Review 6.  Factors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals.

Authors:  Etienne Asonganyi; Meenakshi Vaghasia; Clarissa Rodrigues; Amruta Phadtare; Anne Ford; Ricardo Pietrobon; Julius Atashili; Catherine Lynch
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

7.  Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia.

Authors:  Atalay Mulu Fentie; Tamir Birhanu Tadesse; Gebremedhin Beedemariam Gebretekle
Journal:  BMC Womens Health       Date:  2020-07-16       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.